Reply to Seddon, Schaaf, and Hesseling.
Dooley KE, Mitnick C, Degroote MA, Obuku E, Hamilton CD, Makhene M, Shah S, Brust JC, Durakovic N, Nuermberger E; Efficacy Subgroup, RESIST-TB.
Dooley KE, et al.
Clin Infect Dis. 2013 Jan;56(1):168-9. doi: 10.1093/cid/cis820. Epub 2012 Sep 18.
Clin Infect Dis. 2013.
PMID: 22990846
Free PMC article.
No abstract available.